Nerve Degeneration
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Nerve Composition of Human Lumbar Dorsal Primary Rami and Its Medial Branch
Quantifying the Trainability of Peripheral Nerve Function in Young and Older Adults.
Assessment of Nerve Damage Biomarkers in Acute and Chronic Organophosphate Toxicity
Evaluation of Nerve Regeneration After Nerve Transsection Using (Diffusion-tensor Magnetic Resonance Imaging) DTI MR Imaging
Orange Juice Consumption and Cognitive Function
Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs